2009 swine flu pandemic

2009 swine flu pandemic
HotWikiBR · Public domain · source
Name	2009 H1N1 influenza pandemic
Disease	Influenza A virus subtype H1N1
First outbreak	Veracruz, Mexico
Dates	April 2009 – August 2010
Confirmed cases	~700,000 laboratory-confirmed (est.), millions infected
Deaths	151,700–575,400 estimated global excess deaths
Virus strain	A(H1N1)pdm09
Origin	Reassortment of swine, avian, and human influenza viruses

2009 swine flu pandemic was a global outbreak of a novel influenza A(H1N1)pdm09 virus that emerged in 2009 and caused widespread illness, international public-health mobilization, and extensive media coverage. The pandemic prompted coordinated responses from organizations such as the World Health Organization, Centers for Disease Control and Prevention, and Pan American Health Organization, and affected nations including Mexico, United States, Canada, United Kingdom, Australia, and India.

Background

The emergence occurred against a backdrop of past influenza events such as the 1918 influenza pandemic, 1957 influenza pandemic, and 1968 flu pandemic, and within surveillance networks like the Global Influenza Surveillance and Response System, coordinated by the World Health Organization and national agencies including the Public Health Agency of Canada, European Centre for Disease Prevention and Control, and China Center for Disease Control and Prevention. Preparedness efforts referenced materials from the National Pandemic Influenza Preparedness and Response frameworks of the United States Department of Health and Human Services, United Kingdom Department of Health and Social Care, Australian Department of Health, and plans of the European Commission and Gavi, the Vaccine Alliance. Laboratories such as the Centers for Disease Control and Prevention's Influenza Division, the National Microbiology Laboratory (Canada), and the CDC Influenza Branch mobilized alongside academic centers including Johns Hopkins University, Imperial College London, University of Toronto, Harvard University, and University of Oxford.

Outbreak and Spread

Initial clusters were identified in La Gloria, Veracruz, San Luis Potosí, and Mexico City, with early cases detected by Mexican institutions including the Secretaría de Salud (Mexico) and reported internationally through the World Health Organization pandemic alert system. Rapid international spread was documented through travel-linked cases in United States, Canada, Spain, United Kingdom, France, Germany, Japan, Australia, New Zealand, China, and India via major hubs such as John F. Kennedy International Airport, Los Angeles International Airport, Toronto Pearson International Airport, Heathrow Airport, and Charles de Gaulle Airport. Countries invoked responses from ministries like the Ministry of Health (Brazil), Ministry of Health and Family Welfare (India), Ministry of Health and Social Affairs (Sweden), and institutions including National Institutes of Health (United States), Institut Pasteur, Robert Koch Institute, Korea Centers for Disease Control and Prevention, and Japanese National Institute of Infectious Diseases. Surveillance data were reported to entities such as European Influenza Surveillance Network and coordinated during international meetings at venues like the World Health Assembly.

Virology and Origins

Genetic characterization by laboratories including the Centers for Disease Control and Prevention, National Microbiology Laboratory (Canada), and Erasmus Medical Center revealed a reassortant A(H1N1) virus combining gene segments from North American swine influenza, Eurasian swine influenza, avian influenza, and human seasonal influenza lineages. Sequencing work from groups at Scripps Research Institute, Wellcome Sanger Institute, Mount Sinai School of Medicine, University of Wisconsin–Madison, and University of California, San Diego clarified relationships to earlier strains identified by surveillance in Mexico, United States, and China. Research teams led by investigators at Centers for Disease Control and Prevention and Institut Pasteur explored antigenic properties, receptor binding, and transmissibility in models used at Rocky Mountain Laboratories, Mount Sinai, and St. Jude Children's Research Hospital. The virus was designated A/California/07/2009-like (H1N1)pdm09 in vaccine strain recommendations by the World Health Organization's biannual consultations with representatives from Food and Agriculture Organization and World Organisation for Animal Health.

Public Health Response and Interventions

Public-health measures ranged from non-pharmaceutical interventions recommended by the World Health Organization and implemented by national bodies such as the Centers for Disease Control and Prevention, Public Health England, Health Canada, and Ministry of Health (Brazil), to pharmaceutical responses including antiviral distribution by manufacturers like GlaxoSmithKline, Roche, Novartis, and Sanofi Pasteur. Vaccination campaigns developed by firms including Novartis Vaccines, Sanofi Pasteur, GlaxoSmithKline Vaccines, and Baxter International used WHO-recommended A(H1N1)pdm09 antigens. International coordination occurred through World Health Organization mechanisms, procurement via Pan American Health Organization, and funding facilitated by United Nations, World Bank, and Gavi, the Vaccine Alliance. Travel advisories involved agencies like the U.S. Department of State, European Commission, and national ministries such as the Ministry of Health (Japan). Hospital surge planning engaged institutions including Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, and Royal Melbourne Hospital.

Impact and Consequences

The pandemic caused widespread morbidity with hospitalizations documented by the Centers for Disease Control and Prevention, Public Health Agency of Canada, European Centre for Disease Prevention and Control, and Australian Department of Health; notable mortality burdens were analyzed by research groups at Imperial College London, Johns Hopkins Bloomberg School of Public Health, University of Toronto Dalla Lana School of Public Health, and Harvard School of Public Health. Economic effects were assessed by International Monetary Fund, World Bank, and Organisation for Economic Co-operation and Development with impacts on sectors tracked by agencies such as the U.S. Bureau of Labor Statistics and Eurostat. The pandemic influenced policy and legislation including revisions to the International Health Regulations (2005), national preparedness statutes such as the Pandemic and All-Hazards Preparedness Act, and organizational changes at Centers for Disease Control and Prevention and World Health Organization. Scientific outcomes included accelerated work on universal influenza vaccines at National Institute of Allergy and Infectious Diseases, expanded influenza surveillance networks involving GISAID, and clinical trials at centers like Fred Hutchinson Cancer Research Center.

Controversies and Criticisms

Debates arose over the WHO pandemic declaration process, interactions with pharmaceutical manufacturers such as Sanofi, GlaxoSmithKline, and Novartis, and transparency in advisories involving participants from European Medicines Agency, Food and Drug Administration, Advisory Committee on Immunization Practices, and national immunization technical advisory groups like National Immunization Technical Advisory Group (United Kingdom). Criticisms targeted testing policies at entities including the Centers for Disease Control and Prevention and Public Health England, vaccine prioritization decisions by ministries of health in Mexico, United Kingdom, and United States Department of Health and Human Services, and media coverage by outlets such as BBC, The New York Times, The Guardian, Al Jazeera, and CNN. Legal and ethical questions involved procurement contracts reviewed by bodies like the European Court of Auditors, domestic parliaments including House of Commons (United Kingdom), United States Congress, and Senate of Mexico. Post-pandemic inquiries and reviews were conducted by panels convened by World Health Organization, the Council of Europe, national audit offices including the UK National Audit Office and Government Accountability Office (United States).

Category:Influenza pandemics